Buprenorphine injection in Melbourne, Australia - An update

Drug and Alcohol Review

Volumn 27, Issue 2, 2008, Pages 197-199

  Aitken, Campbell K ^a,b   Higgs, Peter G ^a,b   Hellard, Margaret E ^a,b  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b BURNET INSTITUTE   (Australia)

Author keywords

Australia; buprenorphine injection; harm reduction; Melbourne

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC AGENT;

ADDICTION; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DRUG ABUSE; HARM REDUCTION; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PROSPECTIVE STUDY; RESIDENTIAL CARE; STATISTICS; SUBSTANCE ABUSE;

AUSTRALIA; BUPRENORPHINE; CATCHMENT AREA (HEALTH); COHORT STUDIES; CROSS-SECTIONAL STUDIES; HARM REDUCTION; HEPATITIS C; HUMANS; INJECTIONS, INTRAVENOUS; METHADONE; NARCOTICS; NEEDLE SHARING; PROSPECTIVE STUDIES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 38949120061     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701829553     Document Type: Article

References (18)

1. Taylor B. Drugs and Poisons Unit, Rural & Regional Health & Aged Care Services, Department of Human Services Victoria, June 2006.
2. Aboltins CA, Allen P, Daffy JR. Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species. Medical Journal of Australia 2005;182(8):427.
3. Jenkinson RA, Clark NC, Fry CL, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction 2005;100:197-205.
4. Luty J, O'Gara C, Sessay M. Is methadone too dangerous for opiate addiction? British Medical Journal 2005;331:1352-3.
5. Loo HW, Yam AKT, Tan TC, Peng YP, Teoh LC. Severe upper limb complications from parenteral abuse of Subutex. Ann Acad Med Singapore 2005;34:575-8.
6. Auriacombe M, Fatseas M, Dubernet J, Daulouede J, Tignol J. French field experience with buprenorphine. American Journal on Addiction 2004;13:S17-S28.
7. Feeney GFX, Fairweather P. Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets. Drug and Alcohol Review 2003;22:359-61.
8. Robinson GM, Dukes PD, Robinson BJ, Cooke RR, Mahoney GN. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Drug and Alcohol Dependence 1993;33:81-6.
9. Forsyth AJM, Farquhar D, Gemmell M, Shewan D, Davies JB. The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland). Drug and Alcohol Dependence 1993;32:277-80.
10. Singh RA, Mattoo SK, Malhotra A, Varma VK. Cases of buprenorphine abuse in India. Acta Psychiatrica Scandinavica 1992;86:46-8.
11. Alho H, Sinclair D, Vuori E, Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 2007;88(1):75-8.
12. Lintzeris N, Lenne M, Ritter A. Methadone injecting in Australia: a tale of two cities. Addiction 1999;94(8): 1175-8.
13. Vidal-Trecan G, Varescon I, Nabet N, Boissonnas A. Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug and Alcohol Dependence 2003;69(2):175-81.
14. Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti JP. Injecting misuse of buprenorphine among French drug users. Addiction 2001;96(2):267-72.
15. Dietze P, Fitzgerald J. Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles? Drug and Alcohol Review 2002;21(3):295-303.
16. Cazorla C, Grenier de Cardenal D, Schuhmacher H, Thomas L, Wack A, May T, Rabaud C. Infectious complications and misuse of high-dose buprenorphine. Presse Med 2005;34(10):719-24.
17. Topp L. Pharmaceutical diversion: accidental harm reduction? Of Substance 2006;4(2):6-9.
18. Lintzeris N, Strang J, Metrebian N, Byford S, Hallam C, Lee S, Zador D; RIOTT Group. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduct J 2006;27:3-28.